These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 33287942)
1. miR-409-3p inhibits the proliferation and migration of human ovarian cancer cells by targeting Rab10. Li Y; Chen L; Zhang B; Ohno Y; Hu H Cell Mol Biol (Noisy-le-grand); 2020 Oct; 66(7):197-201. PubMed ID: 33287942 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-135a-3p is downregulated and serves as a tumour suppressor in ovarian cancer by targeting CCR2. Duan S; Dong X; Hai J; Jiang J; Wang W; Yang J; Zhang W; Chen C Biomed Pharmacother; 2018 Nov; 107():712-720. PubMed ID: 30138893 [TBL] [Abstract][Full Text] [Related]
3. MiR-520a-3p inhibits malignant progression of epithelial ovarian cancer by targeting SUV39H1 expression. Li J; Shao W; Zhao J Hum Cell; 2021 Mar; 34(2):570-578. PubMed ID: 33196969 [TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA HOTTIP promotes the metastatic potential of ovarian cancer through the regulation of the miR-615-3p/SMARCE1 pathway. Wu H; Wei HY; Chen QQ Kaohsiung J Med Sci; 2020 Dec; 36(12):973-982. PubMed ID: 32783402 [TBL] [Abstract][Full Text] [Related]
5. MiR-126-3p inhibits ovarian cancer proliferation and invasion via targeting PLXNB2. Xiang G; Cheng Y Reprod Biol; 2018 Sep; 18(3):218-224. PubMed ID: 30054097 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-134-3p is a novel potential inhibitor of human ovarian cancer stem cells by targeting RAB27A. Chang C; Liu T; Huang Y; Qin W; Yang H; Chen J Gene; 2017 Mar; 605():99-107. PubMed ID: 28043921 [TBL] [Abstract][Full Text] [Related]
7. MiR-203a-3p regulates the biological behaviors of ovarian cancer cells through mediating the Akt/GSK-3β/Snail signaling pathway by targeting ATM. Liu HY; Zhang YY; Zhu BL; Feng FZ; Zhang HT; Yan H; Zhou B J Ovarian Res; 2019 Jul; 12(1):60. PubMed ID: 31277702 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-299-3p regulates proliferation, migration and invasion of human ovarian cancer cells by modulating the expression of OCT4. Zhao R; Liu Q; Lou C Arch Biochem Biophys; 2018 Aug; 651():21-27. PubMed ID: 29758200 [TBL] [Abstract][Full Text] [Related]
9. ELFN1-AS1 accelerates cell proliferation, invasion and migration via regulating miR-497-3p/CLDN4 axis in ovarian cancer. Jie Y; Ye L; Chen H; Yu X; Cai L; He W; Fu Y Bioengineered; 2020 Dec; 11(1):872-882. PubMed ID: 32779991 [TBL] [Abstract][Full Text] [Related]
10. MiR-409-3p regulates the proliferation and apoptosis of THP-1 through targeting Rab10. Xie W; Wang Z; Guo X; Guan H Leuk Res; 2023 Sep; 132():107350. PubMed ID: 37437422 [TBL] [Abstract][Full Text] [Related]
11. MiR-15a-3p suppresses the growth and metastasis of ovarian cancer cell by targeting Twist1. Fan B; Chen LP; Yuan YH; Xiao HN; Lv XS; Xia ZY Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1934-1946. PubMed ID: 30915736 [TBL] [Abstract][Full Text] [Related]
12. LINC00339 promotes cell proliferation, migration, and invasion of ovarian cancer cells via miR-148a-3p/ROCK1 axes. Pan L; Meng Q; Li H; Liang K; Li B Biomed Pharmacother; 2019 Dec; 120():109423. PubMed ID: 31550677 [TBL] [Abstract][Full Text] [Related]
13. circ-CSPP1 promotes proliferation, invasion and migration of ovarian cancer cells by acting as a miR-1236-3p sponge. Li QH; Liu Y; Chen S; Zong ZH; Du YP; Sheng XJ; Zhao Y Biomed Pharmacother; 2019 Jun; 114():108832. PubMed ID: 30965236 [TBL] [Abstract][Full Text] [Related]
14. miR-590-3p Promotes Ovarian Cancer Growth and Metastasis via a Novel FOXA2-Versican Pathway. Salem M; O'Brien JA; Bernaudo S; Shawer H; Ye G; Brkić J; Amleh A; Vanderhyden BC; Refky B; Yang BB; Krylov SN; Peng C Cancer Res; 2018 Aug; 78(15):4175-4190. PubMed ID: 29748371 [TBL] [Abstract][Full Text] [Related]
15. MiR-574-3p exerts as a tumor suppressor in ovarian cancer through inhibiting MMP3 expression. Zheng J; Zhou Y; Li XJ; Hu JM Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6839-6848. PubMed ID: 31486483 [TBL] [Abstract][Full Text] [Related]
16. MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer. Xu H; Mao HL; Zhao XR; Li Y; Liu PS J Ovarian Res; 2020 Mar; 13(1):31. PubMed ID: 32192508 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival. Fu X; Li Y; Alvero A; Li J; Wu Q; Xiao Q; Peng Y; Hu Y; Li X; Yan W; Guo K; Zhou W; Wang Y; Liu J; Zhang Y; Mor G; Wen J; Yin G Oncotarget; 2016 Dec; 7(49):80633-80654. PubMed ID: 27811362 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-367-3p directly targets RAB23 and inhibits proliferation, migration and invasion of bladder cancer cells and increases cisplatin sensitivity. Wei X; Jiang Y; Yang G; Chang T; Sun G; Chen S; Wu S; Liu R J Cancer Res Clin Oncol; 2023 Dec; 149(20):17807-17821. PubMed ID: 37935937 [TBL] [Abstract][Full Text] [Related]
19. Targeting miR-21-3p inhibits proliferation and invasion of ovarian cancer cells. Báez-Vega PM; Echevarría Vargas IM; Valiyeva F; Encarnación-Rosado J; Roman A; Flores J; Marcos-Martínez MJ; Vivas-Mejía PE Oncotarget; 2016 Jun; 7(24):36321-36337. PubMed ID: 27166999 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-223-3p Regulates Ovarian Cancer Cell Proliferation and Invasion by Targeting SOX11 Expression. Fang G; Liu J; Wang Q; Huang X; Yang R; Pang Y; Yang M Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]